Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Tuesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
NYSE AMPE opened at $0.00 on Tuesday. The stock has a market cap of $2,951.00, a P/E ratio of 0.00 and a beta of 2.21. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $7.47. The company’s 50-day simple moving average is $0.06 and its 200 day simple moving average is $0.59.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- How to Effectively Use the MarketBeat Ratings Screener
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- Bank Stocks – Best Bank Stocks to Invest In
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
